Baloxavir: First Global Approval

Overview of attention for article published in Drugs, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 4,480 followers.

Drugs -- Baloxavir: First Global Approval /Baloxavir marboxil (Xofluza™; baloxavir) is an oral cap-dependent endonuclease inhibitor #influenza https://t.co/Wy6KO11skO https://t.co/wNH34L22RY